What is the address of MEDIMAD?

The registered office of MEDIMAD is located at Frans Vekemansstraat 117, 1120 Brussel.

Is MEDIMAD still active?

Yes. According to the CBE (30 October 2026) MEDIMAD is active, legal situation “Normale toestand”, started on 19 July 2016.

Is MEDIMAD registered on Peppol?

Yes, MEDIMAD is registered on the Peppol network with ID 0208:0659777469.

What is the enterprise number of MEDIMAD?

The enterprise number of MEDIMAD is BE0659777469.

When was MEDIMAD founded?

MEDIMAD was founded on 19 July 2016.

Is MEDIMAD a reliable company?

Databakkes does not pass judgement; this is what the sources say: Active according to the CBE since 19 July 2016; 5 annual accounts filed, latest fiscal year 2025.

How much profit did MEDIMAD make in 2025?

MEDIMAD posted a profit after taxes of € 211,344 in financial year 2025.

What is the revenue of MEDIMAD?

As a small company, MEDIMAD is not required to publish revenue in its annual accounts. In financial year 2025, its added value was € 312,073.

MEDIMAD (Private Limited) - Brussel - BE0659777469

Dossier MEDIMAD, printed on 30 October 2026 from databakkes.be/en/0659777469/medimad. Sources: CBE, National Bank of Belgium, Belgian Official Gazette.

Financials

Financial year 2025

MEDIMAD from Brussel, company number BE0659777469, closed financial year 2025 with a result of € 211,344 after tax. For that financial year MEDIMAD recorded a gross margin of € 312,073 and equity of € 24,233. Compared with financial year 2024, the result moved from € 175,978 to € 211,344. Profitable, and profit is growing. The buffer shrank hard: equity is 67 % below last year. High debts against a small own buffer. The most recent annual accounts were filed with the National Bank of Belgium on May 31, 2026.

What it is worth Shrank hard

€ 24,233

▼ 67% vs 2024

Assets minus debts, by the books. What is left if everything were sold and paid today.

Profit Growing

€ 211,344

▲ 20% vs 2024

Profit after tax over the fiscal year.

Cash in the bank

€ 483,733

▲ 22% vs 2024

Cash and bank balances on the last day of the fiscal year.

Where the profit goes Pays out

€ 260,000 paid out

More than the year’s profit went to the shareholders; reserves fell.

Debts at end 2025

Bank debt ≈ 12 years to go The accounts give the long-term loan and the part due within the year. The remainder divided by that part is the number of years at an equal pace; a new loan or early repayment changes it.

€ 343,455

▲ 19% vs 2024

€ 25,904 is repaid this year. At this pace the long-term loan is gone in ≈ 12 years.

Owed to suppliers

€ 4,354

▼ 89% vs 2024

Supplier invoices still open on the last day of the fiscal year.

Taxes

€ 17,000

▼ 61% vs 2024

Corporate tax and VAT still to pay. No wage debt: nothing outstanding to staff or social security.

Key figures per fiscal year Download key figures (CSV)
	2022	2023	2024	2025	Change 2024 → 2025
Gross margin	€ 189,784 Gross margin 2022: € 189,784 First fiscal year in the series	€ 208,501 Gross margin 2023: € 208,501 ▲ 10% vs 2022 (€ 189,784) Favourable step	€ 271,988 Gross margin 2024: € 271,988 ▲ 30% vs 2023 (€ 208,501) Favourable step	€ 312,073 Gross margin 2025: € 312,073 ▲ 15% vs 2024 (€ 271,988) Favourable step	▲ 15%
Profit after taxes	€ 137,321 Profit after taxes 2022: € 137,321 First fiscal year in the series	€ 149,316 Profit after taxes 2023: € 149,316 ▲ 9% vs 2022 (€ 137,321) Favourable step	€ 175,978 Profit after taxes 2024: € 175,978 ▲ 18% vs 2023 (€ 149,316) Favourable step	€ 211,344 Profit after taxes 2025: € 211,344 ▲ 20% vs 2024 (€ 175,978) Favourable step	▲ 20%
Equity	€ 177,595 Equity 2022: € 177,595 First fiscal year in the series	€ 76,912 Equity 2023: € 76,912 ▼ 57% vs 2022 (€ 177,595) Unfavourable step	€ 72,889 Equity 2024: € 72,889 ▼ 5% vs 2023 (€ 76,912) Unfavourable step	€ 24,233 Equity 2025: € 24,233 ▼ 67% vs 2024 (€ 72,889) Unfavourable step	▼ 67%
Total debts	€ 310,544 Total debts 2022: € 310,544 First fiscal year in the series	€ 609,124 Total debts 2023: € 609,124 ▲ 96% vs 2022 (€ 310,544) Unfavourable step	€ 603,922 Total debts 2024: € 603,922 ▼ 1% vs 2023 (€ 609,124) Favourable step	€ 769,627 Total debts 2025: € 769,627 ▲ 27% vs 2024 (€ 603,922) Unfavourable step	▲ 27%
Cash	€ 179,957 Cash 2022: € 179,957 First fiscal year in the series	€ 196,581 Cash 2023: € 196,581 ▲ 9% vs 2022 (€ 179,957) Favourable step	€ 397,436 Cash 2024: € 397,436 ▲ 102% vs 2023 (€ 196,581) Favourable step	€ 483,733 Cash 2025: € 483,733 ▲ 22% vs 2024 (€ 397,436) Favourable step	▲ 22%
Land & buildings	€ 278,950 Land & buildings 2022: € 278,950 First fiscal year in the series	€ 271,491 Land & buildings 2023: € 271,491 ▼ 3% vs 2022 (€ 278,950) Unchanged	€ 264,032 Land & buildings 2024: € 264,032 ▼ 3% vs 2023 (€ 271,491) Unchanged	€ 302,922 Land & buildings 2025: € 302,922 ▲ 15% vs 2024 (€ 264,032) Unchanged	▲ 15%
Retained profit	€ 158,995 Retained profit 2022: € 158,995 First fiscal year in the series	€ 58,312 Retained profit 2023: € 58,312 ▼ 63% vs 2022 (€ 158,995) Unfavourable step	€ 54,289 Retained profit 2024: € 54,289 ▼ 7% vs 2023 (€ 58,312) Unfavourable step	€ 5,633 Retained profit 2025: € 5,633 ▼ 90% vs 2024 (€ 54,289) Unfavourable step	▼ 90%
Dividend	€ 0 Dividend 2022: € 0 First fiscal year in the series	€ 250,000 Dividend 2023: € 250,000 Unchanged (€ 0) Unchanged	€ 180,000 Dividend 2024: € 180,000 ▼ 28% vs 2023 (€ 250,000) Unchanged	€ 260,000 Dividend 2025: € 260,000 ▲ 44% vs 2024 (€ 180,000) Unchanged	▲ 44%
Bank debt	€ 280,167 Bank debt 2022: € 280,167 First fiscal year in the series	€ 291,783 Bank debt 2023: € 291,783 ▲ 4% vs 2022 (€ 280,167) Unfavourable step	€ 287,584 Bank debt 2024: € 287,584 ▼ 1% vs 2023 (€ 291,783) Favourable step	€ 343,455 Bank debt 2025: € 343,455 ▲ 19% vs 2024 (€ 287,584) Unfavourable step	▲ 19%
Balance sheet total	€ 488,140 Balance sheet total 2022: € 488,140 First fiscal year in the series	€ 686,035 Balance sheet total 2023: € 686,035 ▲ 41% vs 2022 (€ 488,140) Unchanged	€ 676,811 Balance sheet total 2024: € 676,811 ▼ 1% vs 2023 (€ 686,035) Unchanged	€ 793,860 Balance sheet total 2025: € 793,860 ▲ 17% vs 2024 (€ 676,811) Unchanged	▲ 17%

Key figures of MEDIMAD, fiscal years 2022 to 2025, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2026) expected before 30 April 2027.

What happened to MEDIMAD?

What happened at MEDIMAD in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:

May 31, 2026 New annual accounts for financial year 2025: profit of € 211,344 (▲ 20% vs 2024). filed late Source: NBB ↗
Jul 19, 2016 New establishment in Kraainem. KBO
Jul 19, 2016 Start of the company according to the CBE. KBO

In short

From € 137,321 profit in 2022 to € 211,344 profit in 2025.

Paid € 210,097 in corporate taxes since 2022.

Best year ever: 2025, with € 211,344 profit.

Paid out € 690,000 in dividends to the owners in total.

Original PDFs at the National Bank ↗

Establishments

Establishment units

Physical locations of this company

Registered office

Frans Vekemansstraat 117

1120 Brussel

2.309.701.444

Frans Cloetensstraat 10

1950 Kraainem

Active since 19 July 2016

Who else lives here?

A building full of entrepreneurs or one very busy letterbox? Another 4 companies are registered at this address.

All companies at this address →

V.D.V. CONSEIL

€ 601,754 gross margin · 2025

HOP TRADE

€ -2,089 gross margin · 2025

Vereniging van mede-eigenaars "Frans Vekemans 117" te 1120 Brussel

DNP CONSULTING

€ 75,488 gross margin · 2025

What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.

Details

Company number: 0659.777.469
VAT number: BE 0659.777.469
Registered office: Frans Vekemansstraat 117, 1120 Brussel
Names & denominations: MEDIMAD
Enterprise type: Rechtspersoon
Legal form: Private limited company
Legal situation: Normale toestand
Start date: 19 July 2016
Peppol: Active · Active since 1 Mar 2026

View on CBE Public ↗ Annual accounts (NBB) ↗

MEDIMAD